limit the virus burden in both groups of animals; (iii) the virus burden is reduced in the DU-FIV-infected cats, particularly in tissues such as spleen and saHvary gland; and (iv) the mutation frequency in DU-FIVs integrated in the DNA of primary macrophages after 9 months of infection is -5-fold greater than the frequency observed in DU-FIV DNA integrated in T lymphocytes. Mutation rate with wild-type FIV remains the same in both cell types in vivo. The dominant mutations seen in macrophages with DU-FIV are G -*A base changes, consistent with an increased misincorporation of deoxyuridine into viral DNA of DU-FIVs during reverse transcription. Because this enzyme is absent from human immunodeficiency virus type 1 and other primate lentiviruses, virus replication in cell environments with low DU activity may lead to increased mutation and contribute to the rapid expansion of the viral repertoire.
Feline immunodeficiency virus (FIV) is the lentivirus found associated with a debilitating immune deficiency syndrome of the domestic cat (1) . The cat lentivirus shares many properties with other lentiviruses, including the human counterpart, human immunodeficiency virus (HIV) (for review, see ref.
2).
However, FIV is distinct from the primatL lentiviruses in many respects, a major difference being that the feline lentivirus encodes an additional enzyme, deoxyuridine-triphosphatase (DU; EC 3.6.1.23) within the enzyme cassette encoded by the pol gene (3) . Other nonprimate lentiviruses, such as equine infectious anemia virus, visna, and caprine encephalitis virus, also encode DU (3) (4) (5) . On the basis of the overall conservation of pol between the nonprimate and primate lentiviruses, it is probable that the primate lentiviruses lost DU sometime during speciation. Regardless, determining the role of this enzyme in the life cycle of DUIJ retroviruses will likely provide insight into DU-retroviruses, such as HIV-1.
Studies performed in vitro with DU-FIV (6), as well as with equine infectious anemia virus (5) , have shown that DUviruses can grow to near wild-type levels in actively dividing cells, such as mitogen-stimulated T lymphocytes and permissive cell lines, but fail to grow productively in nondividing cells, such as primary macrophages. These results are interpreted to mean that DU function can be "borrowed" from the host cell when in sufficient quantity, such as in actively dividing T cells. DU-mutants do not fare well in primary macrophages, probably due to low endogenous levels of the host cell enzyme. The implication is that misincorporation of deoxyuridine in the DU-viruses is mutagenic, as occurs in dut-bacterial strains (7, 8) , resulting in defective virus production.
The purpose of the present study was to carry the experiment one step further, by assessing the consequences of loss of DU on in vivo growth properties of FIV. As shown below, the loss of DU causes alterations in the tissue distribution of the virus and results in an increased frequency of mutation of the viral genome.
MATERIALS AND METHODS
Virus Strains and Inoculation Protocols. Inoculations were performed with either wild-type FIV-PPR strain (9) or FIV-PPR that had been modified to contain an in-frame insertion in the middle of the genomic region encoding DU (6) . Four specific-pathogen free (SPF) cats, 7 weeks of age, were injected i.v. with 300 median tissue culture infective dose (TCID5o) units of FIV-PPR that had been propagated in peripheral blood mononuclear cells (PBMCs). An additional four agematched animals were inoculated similarly with the same dose of DU-FIV-PPR. Animals were infected as described (10) and monitored for humoral antibody responses, antigenemia, and virus recovery by cocultivation of infected and control PBMCs. Animals were also assessed for appearance and severity of acute-phase symptoms, as described (10 employed to assess antigenemia in infected cats. The primary antibody bound to microtiter wells (177 ng per well in 10 mM Tris-HCl, pH 8.5/150 mM NaCl) was a monoclonal antibody (PAK-32C) to CA (provided by C. Grant, Custom Monoclonals, West Sacramento, CA). The secondary anti-CA antibody was a rabbit antipeptide serum prepared against the peptide sequence AEYDRTHPPDAPRPL(C). Viruscontaining sample (serum, cerebrospinal fluid, tissue culture supernatant, or virus in PBS) was made 1% with Nonidet P-40 to disrupt the virions and then added in a 1:1 dilution series in BLOTTO to the plate coated with primary antibody. The plates were incubated at 37°C for 1 h, washed, and then incubated with rabbit anti-CA antibody (1:100) for 1 h at 37°C. After being washed with PBS/Tween 20, plates were incubated with peroxidase conjugated goat anti-rabbit IgG (1:500) for 1 h at 37°C and then washed as above. Peroxidase chromogenic substrate 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (Kirkegaard & Perry Laboratories) was added, and the plates were read at 405 nm.
Reverse Transcriptase (RT) Assays. Virus-containing supernatant (4 ml) was centrifuged at 55,000 x g for 1 h at 4°C. The centrifuge tubes were drained and swabbed to remove any residual medium and then assayed for RT activity as described (6) .
Periferal Blood Mononuclear Cells and Primary Macrophage Preparation. Whole, heparinized cat blood was diluted 1:2.5 in sterile Hanks' buffered salt solution (HBSS) and layered over an equal volume of Ficoll-Paque (Pharmacia). The sample was then centrifuged at 2000 rpm (Beckman model J6-B) for 30 min at 4°C, and the white blood cells were removed from the HBSS/Ficoll interface and pelleted at 1000 rpm for 5 min. The cell pellet was resuspended in HBSS and washed three times prior to cell culture.
Total peripheral blood mononuclear cells were cultured for 24 h in RPMI 1640 medium containing 15% (vol/vol) fetal bovine serum (FBS), 7.5 ,g of Con A (Sigma) per ml, 55 nM 2-mercaptoethanol, and 100 units of human recombinant interleukin 2 (IL-2) (a gift of Hofmann-La Roche) per ml. Nonadherent cells were then removed and cultured in the same medium. These cells were 99% T lymphocytes as determined by fluorescence analysis using a T-cell specific monoclonal antibody (CAG5-3D; provided by C. Grant). The adherent cells (-98% positive for nonspecific esterase) were fed with RPMI 1640 medium containing 15% (vol/vol) FBS but lacking Con A and IL-2. This cell population is designated as primary macrophages. DU Assays. DU activity was measured in whole-cell extracts essentially as described (12) . Briefly, 107 cells prepared from normal peripheral blood lymphocytes as detailed above, were lysed in the presence of 0.5% Nonidet P-40 in 50 mM Tris HCl, pH 7.5/5 mM MgCl2/2 mM 2-mercaptoethanol. The samples were centrifuged at 8000 x g for 5 min to remove insoluble material, and the supernatants were standardized to equivalent protein concentrations by dilution dot-blot analyses (13) . Assays were then performed in the same buffer by using deoxy[5-3H]uridine 5'-triphosphate (Amersham) as substrate at 30°C. dNTPs other than dUTP were added to act as a sink for potential nonspecific phosphatase activities in the wholecell extracts. However, no significant differences were noted in the relative rates of dUTP cleavage by extracts from T-lymphocyte-enriched or macrophage-enriched cell populations as a function of dNTP addition. PCR Analysis. DNA was prepared from cat tissues as described (14) . Aliquots (10 ,ug) were then subjected to 35 cycles of amplification by PCR by using primers corresponding to the limits of nucleotides 3661-4384 of full-length FIV, which includes the RNase H and DU domains of pol (9) (plus-strand primer, 5'-GGTATATAGATGGAGCTAGA-AAGCTAGG-3'; minus-strand primer, 5'-GACCCATAAC-CTTTTTCTCCTCTCTC-3'). Amplification cycle times were as follows: denaturation, 30 sec at 94°C; annealing, 2 min at 60°C; and extension, 2 min at 72°C. All DNA samples were subjected to identical conditions and number of cycles of amplification. Amplification products were cloned and analyzed by nucleotide sequencing by using Sequenase (United States Biochemical). The DU gene segment from DU-FIV was readily distinguishable from wild-type FIV by the presence of an Sph I restriction site and lack of an EcoRV restriction site, a circumstance created by insertion of an in-frame oligonucleotide that abrogates DU activity, while maintaining an open reading frame in pci (6) . To control for PCR-induced mutations, amplifications were performed on plasmid-borne FIV pol sequences by using conditions identical to those employed on genomic DNA sequences. The nucleotide sequences of six clones resulting from this amplification were all identical, indicating a high fidelity of PCR under the conditions employed.
RESULTS
Four animals were inoculated with wild-type FIV-PPR, and four with DU-FIV-PPR, then followed for development of viremia, immune response to viremia, and clinical signs of acute phase disease for over 1 year. After 4 months of infection, virus was recovered from all infected animals, regardless of whether they were infected with wild-type or DU-FIV. PCR and nucleotide sequence analyses verified that virus recovered from animals infected with DU-FIV still possessed the in-frame insertion in DU and had not reverted to wild type (data not shown). Seroconversion data (Fig. 1 ) indicated that the rate at which the immune response to virus infection occurred was essentially identical in both sets of animals, with a strong humoral antibody response noted between 4 and 6 weeks postinoculation. Increase in antibody titer corresponded to a decrease in antigenemia (Fig. 1C) .
Acute-phase symptoms observed in this study were similar to those previously reported with infection by the FIV-MA strain (10, 15, 16) . Detailed analyses will be described elsewhere (T.R.P., O.P.-G., D. W. Wheeler, P.C.W., D.L.L., H.S.F., L. R. Whalen, F.E.B., J.H.E., and S. J. Henriksen, unpublished data). Lymphadenopathy was a consistent feature of infection by both wild-type and DU-FIV, along with febrile episodes and alteration in several central nervous system (CNS)-related functions, including delayed auditory and visual evoked potential changes and disruption of sleep architecture (T.R.P. et al., unpublished data). We had predicted that disruption of DU might attenuate CNS-related changes, given that macrophages are considered a major vehicle for penetration of the CNS in HIV-1 infection (17) . DU-FIVs are still able to infect macrophages, albeit inefficiently (6) , so this cell type may still be important for virus dissemination in the brain. However, it may also be that macrophages are not a primary source ofvirus in FIV infection of the CNS (18) .
After 9 months of infection, wild-type FIV-infected and DU-FIV-infected animals were sacrificed and analyzed for histological changes and for distribution of virus in various tissues. Except for lymph node follicular hyperplasia, no other tissue abnormalities were observed in either the wild-type or DU-FIV-infected cat at this early stage of infection. PCR analyses of the tissues, however, did detect differences in the virus load and tissue distribution between wild-type and DU-FIV-infected animals (Fig. 2) demonstrated a 5-fold higher mutation frequency compared with wild-type FIV or DU-FIV integrated in the DNA of T lymphocytes ( Table 1 ). The majority of changes were G -> A transitions, consistent with incorporation of deoxyuridine paired with guanine into minus-strand viral DNA during reverse transcription. This could result in substitution of adenine for guanine during plus strand synthesis. No differences were noted in the relative mutation frequencies in RNase H or the mutated DU, indicating that these findings were not simply changes accumulating in a mutated gene product. 80-a -d to assess the relative endogenous DU levels in the ._ 6 1 populations (Fig. 3) . Also, DNA was prepared from cell populations from each experimental group, and uences encompassing the RNase H domain of RT and hages. Time, min results of nucleotide sequence analyses (Table 1) (3, 4, (22) (23) (24) . DU is also an essential part of the genomes of other viruses including the herpes viruses (25, 26) and pox viruses (27 
